guan-fu base a has been researched along with Disease Models, Animal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Gu, N; Liu, J; Liu, K; Liu, S; Wang, H; Xiong, F | 1 |
Cao, S; Fan, Y; Gao, Y; Greffrath, W; Li, G; Li, L; Li, M; Liang, S; Liu, S; Shi, L; Treede, RD; Xu, H; Yang, R; Yi, Z; Yu, K; Yuan, H; Zhang, C; Zou, L | 1 |
2 other study(ies) available for guan-fu base a and Disease Models, Animal
Article | Year |
---|---|
Safety, heart specificity, and therapeutic effect evaluation of Guanfu base A-loaded solid nanolipids in treating arrhythmia.
Topics: Animals; Arrhythmias, Cardiac; Disease Models, Animal; Drug Carriers; Drug Stability; Emulsions; Female; Heterocyclic Compounds, 4 or More Rings; Lipids; Male; Nanostructures; Rats | 2018 |
The Inhibition by Guanfu Base A of Neuropathic Pain Mediated by P2Y
Topics: Analgesics; Animals; Constriction, Pathologic; Cyclic AMP; Disease Models, Animal; Ganglia, Spinal; Glial Fibrillary Acidic Protein; HEK293 Cells; Heterocyclic Compounds, 4 or More Rings; Humans; Male; MAP Kinase Signaling System; Neuralgia; Random Allocation; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; RNA, Messenger; Sciatic Nerve; Tumor Necrosis Factor-alpha | 2019 |